Wary pharma: AstraZeneca sours on UK

In Iran, America is using expensive weaponry against cheap local drones. Can upstart tech companies change the economics – and nature — of conflict? As part of our ongoing series on the US at 250, we examine the impact of the two world wars. And should you ever use an emoji at wo ...  Show more

Can peace hold in Lebanon while Hizbullah remains? Our correspondent weighs the balance of power between government forces and the Iran-backed militia. The resale value of Labubus is falling – who cares? And remembering Swedish death-clearer, Margareta Magnusson. Watch extended c ...  Show more

Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean a ...  Show more

Trade ties between <a href="https://www.economist.com/the-americas/2024/11/17/brazil-courts-china-as-its-musk-feud-erupts-again?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&utm_term= ...

America’s health secretary, RFK Jr, is known for his opposition to vaccines, particularly mRNA jabs, that have the potential to treat a large swathe of diseases. Slashing funding will have long term implications beyond America. Our correspondent visits Britain’s biggest and newes ...  Show more

With China as its new rival, America is reviving old wartime facilities across the Pacific. Our correspondent visits an abandoned airfield that has been given new life. The outlook for climate technology is surprisingly bright. And why the universe of Hello Kitty keeps expanding. ...  Show more